BioSpace News Archive

Business

TAE Life Sciences and AIVITA Biomedical Announce Strategic Partnership to Advance Development of Target Boron Drugs for Glioblastoma

TAE Life Sciences and AIVITA Biomedical Announce Strategic Partnership to Advance Development of Target Boron Drugs for Glioblastoma.

January 4, 2023
·
3 min read
BioMidwest

Forge Biologics, a Leading Manufacturer of Genetic Medicines, to Present at 41st Annual J.P. Morgan Healthcare Conference

Forge Biologics, a Leading Manufacturer of Genetic Medicines, to Present at 41st Annual J.P. Morgan Healthcare Conference.

January 4, 2023
·
2 min read
Deals

Sesen Bio Reiterates Confidence in Pending Merger with Carisma Therapeutics

Sesen Bio, Inc. (Nasdaq: SESN) today issued the following statement reiterating the Company’s confidence in, and commitment to, the pending merger with Carisma Therapeutics Inc. (Carisma) as the best path forward for stockholders.

January 4, 2023
·
14 min read
Cyclo Therapeutics Announces Abstract Accepted for Poster Presentation at the Society for Inherited Metabolic Disorders (SIMD) 44th Annual Meeting

Cyclo Therapeutics Announces Abstract Accepted for Poster Presentation at the Society for Inherited Metabolic Disorders (SIMD) 44th Annual Meeting.

January 4, 2023
·
3 min read
Business

Premier, Inc. to Report Fiscal 2023 Second-Quarter Results and Host Conference Call on February 7, 2023

Premier, Inc. announced that it will release financial results for its fiscal 2023 second quarter on Tuesday, February 7, at approximately 6:30 a.m. EST.

January 4, 2023
·
1 min read
Genetown

Vertex to Present at the 41st Annual J.P. Morgan Healthcare Conference on January 9

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that management will present at the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023 at 11:15 a.m. ET/8:15 a.m. PT.

January 4, 2023
·
1 min read
Business

Belharra Therapeutics Debuts With $130 Million in Funding

Belharra Therapeutics, Inc. today emerged from stealth mode with a novel photoaffinity-based chemoproteomics platform capable of identifying non-covalent, small molecule drug candidates for any protein.

January 4, 2023
·
10 min read
Policy

Sedana Medical receives FDA Fast Track Designation in the United States

Sedana Medical AB announces that the U.S. Food and Drug Administration has granted Fast Track Designation for the evaluation of isoflurane via the Sedaconda ACD-S device for sedation of mechanically ventilated patients in the intensive care setting.

January 4, 2023
·
4 min read
Drug Development

Roivant Announces Statistically Significant and Clinically Meaningful Results from the Induction Period of TUSCANY-2

Roivant Sciences (Nasdaq: ROIV) today announced positive results from the induction period of the TUSCANY-2 Phase 2b study of RVT-3101.

January 4, 2023
·
7 min read
BioMidwest

GE HealthCare Completes Spin-Off and Begins Trading on Nasdaq

GE HealthCare announced that its previously announced spin-off from GE is complete and GE HealthCare will begin trading as an independent company on the Nasdaq exchange under the ticker symbol “GEHC”.

January 4, 2023
·
6 min read